Clinical trials
Recruiting Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 18 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 |
| National Cancer Institute (NCI) | 7 |
| Emory University | 4 |
| Pfizer | 4 |
| M.D. Anderson Cancer Center | 3 |
| Mayo Clinic | 3 |
| Iovance Biotherapeutics, Inc. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| NRG Oncology | 2 |
| Stanford University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 65 |
| Carcinoma, Non-Small-Cell Lung | 20 |
| Laryngeal Neoplasms | 17 |
| Oropharyngeal Neoplasms | 16 |
| Squamous Cell Carcinoma of Head and Neck | 16 |
| Hypopharyngeal Neoplasms | 15 |
| Lung Neoplasms | 15 |
| Neoplasms | 15 |
| Mouth Neoplasms | 14 |
| Melanoma | 8 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.